Seizure reduction and functional recovery with edaravone-levetiracetam versus edaravone-carbamazepine therapy in post-stroke epilepsy

Key Points

• Seizure reduction was more pronounced with edaravone-levetiracetam therapy compared to edaravone-carbamazepine.
• Significant improvement noted in functional recovery, with a marked difference in post-treatment scores.
• Therapy comparison based on observed clinical data over a specified recovery period across a diverse population.
• Implications may guide therapeutic choices for managing post-stroke epilepsy.